← Leaderboards
Brian J. Akerley
University Of Michigan At Ann Arbor
$4,658,223
Attributed
$6,263,163
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $712.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,263,163 · 8
By mechanism
R01$3,669,879 · 2
R41$891,821 · 2
R21$867,255 · 2
R56$834,208 · 2
Top collaborators
- Hao Shen6 shared
- Zehava Eichenbaum2 shared
- Jorge Eugenio Vidal2 shared
- Mary E Marquart1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Janet R Gilsdorf$9,456,555
- Graham P Krasan$572,400
- Eric C Martens$9,107,472
- Mark A Saper$1,919,755
- Tayyab Rehman$169,560
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVirulencePneumoniaHaemophilus InfluenzaeImmune ResponseBlood CirculationGrowthLungMutantGenesPathogenesisOtitis MediaMeningitisEnvironmentBacterial PneumoniaBacteremiaVaccinesInvadedAntigensSymptomsCellsDefectBacteriaLipooligosaccharide
Grant awards (19)
A novel Th17-enhancing adjuvant and conserved antigen for protection against viral/bacterial co-infection$308,669
R41 · FY2025 · AI · contact PI
Mechanisms underlying adhesion and colonization in pneumococcal keratitis$426,250
R21 · FY2023 · EY
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury$286,226
R41 · FY2023 · AI · contact PI
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury$296,926
R41 · FY2022 · AI · contact PI
HEMOGLOBIN-INDUCED VIRULENCE IN STREPTOCOCCUSPNEUMONIAE$194,380
R21 · FY2022 · AI
HEMOGLOBIN-INDUCED VIRULENCE IN STREPTOCOCCUS PNEUMONIAE$246,625
R21 · FY2021 · AI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$379,020
R01 · FY2016 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$379,020
R01 · FY2015 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$392,253
R01 · FY2014 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$383,403
R01 · FY2013 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$237,927
R01 · FY2012 · AI · contact PI
Mechanisms of Haemophilus influenzae pathogenesis in the lung$424,000
R56 · FY2011 · AI · contact PI
Global regulatory interactions in bacterial pathogenesis$410,208
R56 · FY2009 · AI · contact PI
Global regulatory interactions in bacterial pathogenesis$377,525
R01 · FY2006 · AI · contact PI
Global regulatory interactions in bacterial pathogenesis$387,112
R01 · FY2005 · AI
Global regulatory interactions in bacterial pathogenesis$387,592
R01 · FY2004 · AI
Global regulatory interactions in bacterial pathogenesis$388,049
R01 · FY2003 · AI
Global regulatory interactions in bacterial pathogenesis$1
R01 · FY2003 · AI
Global regulatory interactions in bacterial pathogenesis$357,977
R01 · FY2002 · AI